CoreAge Rx vs Midi HRT: product pages, clinical visits and insurance

Look at what happens before prescribing

CoreAge describes an online questionnaire, provider review and delivery when treatment is approved. Its estrogen page now has four named routes, but its current selector still has unfinished order links. Its listed progesterone product also says coming soon. These limits matter when you need to arrange care now.

Midi describes an in-depth virtual appointment to review whether hormone treatment is appropriate. Ask what records to bring and how follow-up will be scheduled. The Midi review covers its service model, while the CoreAge review documents the newly available product information and remaining access questions.

Insurance needs a plan-specific answer

Midi says it is in-network with many PPO plans but directs readers to check their own coverage. Deductibles, copays and coinsurance may apply. A website stating that insurance is accepted does not mean your particular appointment and prescription will both be paid in full.

Its current policy excludes Medicaid and Medi-Cal patients, including self-pay treatment. It describes Medicare beneficiaries as eligible only for self-pay care with restrictions on submitting related claims. These are Midi’s published service policies; readers should confirm their application before booking rather than relying on a general insurance logo.

Cash-pay figures describe different purchases

Midi lists a $250 initial self-pay visit and $150 continued-care visits. Those are appointment fees, not a guarantee that medication and testing are included. Ask the clinic, laboratory and pharmacy which separate charges may arise from the proposed plan.

CoreAge advertises no membership fee but does not currently provide a reliable payable estrogen quote through its public selector. The $64.99 progesterone starting display is paired with a coming-soon notice. Our CoreAge pricing guide explains why those displays cannot be compared directly with Midi’s visit fee as if they purchased the same care.

Match the actual medicine and pharmacy

Midi describes prescribing FDA-approved hormone products and selecting the form through clinical assessment. CoreAge describes several estrogen forms and labels its oral progesterone offer as compounded. Ask for the exact prescription name, route, dispensing pharmacy and approval status instead of inferring them from a general hormone-therapy heading.

If you have a uterus and systemic estrogen is proposed, clarify the complete protection plan. A delayed or unavailable companion medicine is a clinical coordination issue. The progesterone guide can help prepare that conversation without making a treatment choice for you.

Plan for care beyond the first prescription

Find out who handles persistent symptoms, new bleeding, a refill delay or a problem requiring examination. A virtual service should explain when another clinician or in-person assessment is needed. Ask whether your usual healthcare team will receive records and how medicines prescribed elsewhere are reconciled.

For ongoing thyroid treatment, the HRT and thyroid-medication guide describes a concrete reason for coordination. Listing thyroid products on the same website does not automatically establish shared responsibility for two prescriptions or the necessary laboratory follow-up.

Decide what you need to verify next

For Midi, the next practical questions concern appointment access, your specific coverage and the complete out-of-pocket estimate. For CoreAge, first confirm that the advertised hormone pathway is open, obtain a functioning enrollment route and request the finished-product details and total price.

Use the insurance shortlist for other documented models and the appointment planner to prepare a focused list. Neither a broad catalog nor an insurance arrangement can determine which medical plan fits your history.